• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials.

作者信息

Eder Lihi, Pardo Jordi Pardo, Mease Philip, Gensler Lianne S

机构信息

Department of Medicine, Women's College Hospital, University of Toronto, ON, Canada.

Campbell and Cochrane Equity Thematic Group, University of Ottawa, Ottawa, ON, Canada.

出版信息

Rheumatology (Oxford). 2024 Nov 1;63(11):e299-e300. doi: 10.1093/rheumatology/keae356.

DOI:10.1093/rheumatology/keae356
PMID:38985341
Abstract
摘要

相似文献

1
Comment on: Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials.评论：性别和年龄对轴性脊柱关节炎患者生物改善病情抗风湿药疗效的影响：一项随机对照试验的荟萃分析。
Rheumatology (Oxford). 2024 Nov 1;63(11):e299-e300. doi: 10.1093/rheumatology/keae356.
2
'Comment on: Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials': a reply.
Rheumatology (Oxford). 2024 Nov 1;63(11):e301-e302. doi: 10.1093/rheumatology/keae315.
3
Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials.性别和年龄对轴性脊柱关节炎患者生物制剂疗效的影响：一项随机对照试验的荟萃分析。
Rheumatology (Oxford). 2024 Nov 1;63(11):2914-2922. doi: 10.1093/rheumatology/keae088.
4
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results.依奇珠单抗可改善影像学轴向型脊柱关节炎的脊柱疼痛、功能、疲劳、僵硬和睡眠：COAST-V/W 52周结果。
BMC Rheumatol. 2021 Sep 20;5(1):35. doi: 10.1186/s41927-021-00205-3.
5
Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety.乌帕替尼治疗中轴型脊柱关节炎：疗效和安全性的荟萃分析。
Clin Rheumatol. 2024 Aug;43(8):2391-2402. doi: 10.1007/s10067-024-07027-x. Epub 2024 Jun 14.
6
Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review.中轴型脊柱关节炎患者更换生物改善病情抗风湿药物：一项系统文献综述的结果
RMD Open. 2017 Oct 10;3(2):e000524. doi: 10.1136/rmdopen-2017-000524. eCollection 2017.
7
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland.在苏格兰活动性中轴型脊柱关节炎患者中，比美吉珠单抗与白细胞介素-17A抑制剂治疗途径的成本效益。
J Med Econ. 2024 Jan-Dec;27(1):682-696. doi: 10.1080/13696998.2024.2342209. Epub 2024 May 2.
8
Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: A meta-analysis of randomized controlled trials.靶向治疗治疗的银屑病关节炎或中轴型脊柱关节炎患者的感染风险：一项随机对照试验的荟萃分析。
Joint Bone Spine. 2024 May;91(3):105673. doi: 10.1016/j.jbspin.2023.105673. Epub 2023 Nov 30.
9
Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis.生物靶向缓解疾病的抗风湿药物治疗中轴型脊柱关节炎的疗效：系统评价和荟萃分析。
Rheumatology (Oxford). 2020 Nov 1;59(11):3158-3171. doi: 10.1093/rheumatology/keaa268.
10
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies.依奇珠单抗改善影像学轴向型脊柱关节炎的功能和健康：两项关键性研究的第 52 周结果。
J Rheumatol. 2021 Feb;48(2):188-197. doi: 10.3899/jrheum.200093. Epub 2020 Jul 15.

引用本文的文献

1
Sex-Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta-Analysis.中轴型脊柱关节炎随机临床试验中疗效和安全性结果的性别差异：一项系统文献综述和荟萃分析
Arthritis Care Res (Hoboken). 2025 Jul;77(7):813-826. doi: 10.1002/acr.25512. Epub 2025 Mar 19.